Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416007) titled 'Comparison of ultra- and moderate hypofractionation with boost in whole breast and regional node radiotherapy for breast cancer treatment' on April 16.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Pitchayaponne Klunklin
Condition:
Breast cancer patients stage II-III aged 18 years or older who undergo breast conserving surgery with free surgical margins from both invasive carcinoma and ductal carcinoma in situ (DCIS) and are planned to receive whole breast radiation with tumor bed boost with or without regional lymph node radiation.
Ultrahypofractionation, moderated hypofractionation...